These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9312461)

  • 41. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatitis B virus and celiac disease].
    Narváez Rodríguez I; Jiménez Jaén C
    Gastroenterol Hepatol; 2010 Oct; 33(8):617. PubMed ID: 20434813
    [No Abstract]   [Full Text] [Related]  

  • 43. [Liver histology as a predictor of the response to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):975-80. PubMed ID: 7563913
    [No Abstract]   [Full Text] [Related]  

  • 44. [Long-term prognosis of the interferon-treated patients with chronic hepatitis C].
    Yoshida H; Iwabuchi S; Murayama M; Uchikoshi T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):675-9. PubMed ID: 7563855
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.
    Tice JA; Chahal HS; Ollendorf DA
    JAMA Intern Med; 2015 Sep; 175(9):1559-60. PubMed ID: 26167717
    [No Abstract]   [Full Text] [Related]  

  • 46. [Criteria of IFN treatment for chronic hepatitis C].
    Yano M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):986-90. PubMed ID: 7563915
    [No Abstract]   [Full Text] [Related]  

  • 47. Trials wrap on interferon-free hepatitis C regimen.
    Dalzell MD
    Manag Care; 2013 Apr; 22(4):41-2. PubMed ID: 23678562
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of viral load monitoring in predicting which patients with hepatitis C virus will fail interferon therapy.
    Flexman JP; Palladino S; Kay ID; Cheng WS
    Med J Aust; 1999 Sep; 171(6):334. PubMed ID: 10560457
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
    Yoshiba M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):549-56. PubMed ID: 7563822
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of children with chronic hepatitis C with IFN].
    Fujisawa T; Inui A; Komatsu H; Onoue M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):841-6. PubMed ID: 7563886
    [No Abstract]   [Full Text] [Related]  

  • 51. [Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients].
    Dou X; Wei L; Ren H; Zhang H; Zhang W; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):641-3. PubMed ID: 26524354
    [No Abstract]   [Full Text] [Related]  

  • 52. Should acute viral C hepatitis be treated with interferon?
    Desai HG; Gupte PA
    Indian J Gastroenterol; 2005; 24(2):66-7. PubMed ID: 15879653
    [No Abstract]   [Full Text] [Related]  

  • 53. Histologic improvement of fibrosis in patients with hepatitis C and sustained response to interferon therapy.
    Bolaños-Meade J; López-Arvizu C
    Ann Intern Med; 2000 Aug; 133(4):312. PubMed ID: 10929184
    [No Abstract]   [Full Text] [Related]  

  • 54. Interferon treatment of HCV: do we need a virological response?
    Blendis L; Oren R; Halpern Z
    Gastroenterology; 2002 Jan; 122(1):237-8. PubMed ID: 11781302
    [No Abstract]   [Full Text] [Related]  

  • 55. [The era of management of hepatitis c patients].
    Moradpour D; Hadengue A
    Rev Med Suisse; 2011 Sep; 7(307):1667-8. PubMed ID: 21987873
    [No Abstract]   [Full Text] [Related]  

  • 56. [A case of acute posttransfusion hepatitis C of which we can estimate the occurrence by nucleic acid amplification test and cure after therapy with interferon].
    Hakui T; Fujioka T; Hanada K; Seike E; Tounou S; Sitaya M; Mine M; Kondou T
    Nihon Shokakibyo Gakkai Zasshi; 2001 Nov; 98(11):1294-7. PubMed ID: 11729658
    [No Abstract]   [Full Text] [Related]  

  • 57. [Accidental post inoculation of acute hepatitis C in a health care professional with response to interferon treatment].
    Esteve M; Casas I; Planas R; Matas L
    Med Clin (Barc); 2000 Feb; 114(4):157. PubMed ID: 10734627
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of hepatitis C in children.
    Emerick K
    Pediatr Infect Dis J; 2004 Mar; 23(3):257-8. PubMed ID: 15014304
    [No Abstract]   [Full Text] [Related]  

  • 59. Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.
    Cabezas J; Llerena S; Puente Á; Fábrega E; Crespo J
    Rev Esp Enferm Dig; 2016 Jul; 108(7):421-30. PubMed ID: 26666379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agents in development for the treatment of hepatitis C. Summary and table.
    Dunn C; Wilde M; Paterson R
    Drugs R D; 1999 Oct; 2(4):259-64. PubMed ID: 10659405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.